Mibavademab
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for Mibavademab, covering 2026-01-22 to 2026-07-29. Get the full timeline:
Most recent: Clinical Trial Update: A Study of the Safety of Mibavademab in Pediatric and Adult Participants Switching From Metreleptin to Mibavademab for the Treatment of Generalized Lipodystrophy (GLD) [Phase 3]